Encapsulation of Hydrophilic and Hydrophobic Peptides into Hollow Mesoporous Silica Nanoparticles for Enhancement of Antitumor Immune Response

Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer

(2016) Xiangsheng Liu et al.   ACS Nano

Are vacuum-filtrated reduced graphene oxide membranes symmetric?

(2016) Bo Tang et al.   Nanoscale

Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma

(2015) Yuanyuan Guo et al.   ACS Nano

Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy

(2015) Jian Xiang et al.   ACS Nano

Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite

(2015) Xiaohong Hao et al.   ACS Nano

Stimulation of In Vivo Antitumor Immunity with Hollow Mesoporous Silica Nanospheres

(2015) Xiupeng Wang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

The impact of dendritic cell–tumor fusion cells on cancer vaccines - past progress and future strategies

(2015) Mikio Kajihara et al.   Immunotherapy

Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses

(2015) Qin Zeng et al.   JOURNAL OF CONTROLLED RELEASE

MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses

(2015) Martine A. Boks et al.   JOURNAL OF CONTROLLED RELEASE

T lymphocyte-derived TNF and IFN-γ repress HFE expression in cancer cells

(2015) Alexandre Reuben et al.   MOLECULAR IMMUNOLOGY

Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12

(2015) Theofanis Floros et al.   SEMINARS IN ONCOLOGY

Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review

(2015) Eva van Doorn et al.   Human Vaccines & Immunotherapeutics

Fate Mapping of Dendritic Cells

(2015) Mateusz Pawel Poltorak et al.   Frontiers in Immunology

The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their Products

(2015) Luc Van Kaer et al.   Frontiers in Immunology

Nanoparticle-Based Immunotherapy for Cancer

(2014) Kun Shao et al.   ACS Nano

CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire

(2014) L. Robert et al.   CLINICAL CANCER RESEARCH

Th1 cytokine-based immunotherapy for cancer

(2014) Hong-Mei Xu   Hepatobiliary & Pancreatic Diseases International

Detection of Primary Melanoma in Individuals at Extreme High Risk

(2014) Fergal J. Moloney et al.   JAMA Dermatology

Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells

(2013) Min Beom Heo et al.   BIOMATERIALS

Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy

(2013) C. J. Nirschl et al.   CLINICAL CANCER RESEARCH

Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy

(2013) Songwei Tan et al.   Nanomedicine

Engineering Inorganic Nanoemulsions/Nanoliposomes by Fluoride-Silica Chemistry for Efficient Delivery/Co-Delivery of Hydrophobic Agents

(2012) Yu Chen et al.   ADVANCED FUNCTIONAL MATERIALS

Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine

(2012) Masanori Noguchi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines

(2012) Carl R Alving et al.   Expert Review of Vaccines

The specialized roles of immature and mature dendritic cells in antigen cross-presentation

(2012) Richard A. Hopkins et al.   IMMUNOLOGIC RESEARCH

A facile in situ hydrophobic layer protected selective etching strategy for the synchronous synthesis/modification of hollow or rattle-type silica nanoconstructs

(2012) Kun Zhang et al.   JOURNAL OF MATERIALS CHEMISTRY

Nuclear-Targeted Drug Delivery of TAT Peptide-Conjugated Monodisperse Mesoporous Silica Nanoparticles

(2012) Limin Pan et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

(2012) Jason Park et al.   NATURE MATERIALS

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

(2012) Steffen Walter et al.   NATURE MEDICINE

Immunization withLeishmaniaVaccine-Alum-BCG and Montanide ISA 720 Adjuvants Induces Low-Grade Type 2 Cytokines and High Levels of IgG2 Subclass Antibodies in the Vervet Monkey (Chlorocebus aethiops) Model

(2012) J. M. Mutiso et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Adjuvant Properties of Mesoporous Silica Particles Tune the Development of Effector T Cells

(2012) Helen Vallhov et al.   Small

Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery

(2011) Zhiping Zhang et al.   BIOMATERIALS

A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance

(2011) Qianjun He et al.   BIOMATERIALS

Design of immunogenic and effective multi-epitope DNA vaccines for melanoma

(2011) Hyun-Il Cho et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines

(2011) Cheryl Lai-Lai Chiang et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles

(2011) Jixi Zhang et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres

(2011) Xiaoliang Fang et al.   Nanoscale

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses

(2011) James J. Moon et al.   NATURE MATERIALS

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers

(2011) Carlee E. Ashley et al.   NATURE MATERIALS

Reversible Pore-Structure Evolution in Hollow Silica Nanocapsules: Large Pores for siRNA Delivery and Nanoparticle Collecting

(2011) Yu Chen et al.   Small

Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies

(2010) Rebecca Klippstein et al.   Nanomedicine-Nanotechnology Biology and Medicine

Preparation and size determination of monodisperse silica microspheres for particle size certified reference materials

(2010) Sheng-Li Chen et al.   POWDER TECHNOLOGY

Adjuvants for cancer vaccines

(2010) Thomas W. Dubensky et al.   SEMINARS IN IMMUNOLOGY

In vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation

(2010) Qianjun He et al.   Small

Hollow/Rattle-Type Mesoporous Nanostructures by a Structural Difference-Based Selective Etching Strategy

(2009) Yu Chen et al.   ACS Nano

Silica nanoparticle supported lipid bilayers for gene delivery

(2009) Juewen Liu et al.   CHEMICAL COMMUNICATIONS

Mesoporous Silica Nanoparticles with Remarkable Stability and Dispersibility for Antireflective Coatings

(2009) Yasuto Hoshikawa et al.   CHEMISTRY OF MATERIALS

Multipeptide vaccination in cancer patients

(2009) Lorenzo Pilla et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Electrostatically Mediated Liposome Fusion and Lipid Exchange with a Nanoparticle-Supported Bilayer for Control of Surface Charge, Drug Containment, and Delivery

(2009) Juewen Liu et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Porous Nanoparticle Supported Lipid Bilayers (Protocells) as Delivery Vehicles

(2009) Juewen Liu et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Recent Advances in Epitope Design for Immunotherapy of Cancer

(2009) Pieranna Chiarella et al.   Recent Patents on Anti-Cancer Drug Discovery

Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies

(2009) Kimberly A. Chianese-Bullock et al.   VACCINE

A Multipeptide Vaccine is Safe and Elicits T-cell Responses in Participants With Advanced Stage Ovarian Cancer

(2008) Kimberly A. Chianese-Bullock et al.   JOURNAL OF IMMUNOTHERAPY